ORIX Growth Capital completes investment in Zenoss, one of the leading technology companies providing modern monitoring and AI-driven analytics for hybrid and multi-cloud IT environments.
Read MoremiRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company developing proprietary RNA-targeted therapies with a specific focus on microRNAs, today reported financial and operating results for the fourth quarter and full-year ended December 31, 2018.
Read MoreCorporate investments in renewable energy used to be symbolic. A few solar panels here, a small wind farm investment there. But in 2018 some companies became voracious green energy consumers.
Read More